Cardiome pharma stock tsx
7/2/2019 · First on our top pharma stocks TSX year-to-date list is Correvio, previously named Cardiome. This company works on the development and commercialization of cardiovascular therapies. Some of Correvio’s approved products include Aggrastat, Exembol, Brinavess among others. an aggregate total of 210,000 common shares of Cardiome on both the TSX and the NASDAQ on March 26, 2018. Details of the transactions can be found on the System for Electronic Disclosure by Insiders (SEDI). The purchases were made for investment purposes. About Cardiome Pharma Corp.